Kolexia
Etienne Pierre-Luc Oncologie médicale
Etienne Pierre-Luc
Oncologie médicale
Gie Groupement D'imagerie Armoricaine
Plérin, France
87 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du rectum Carcinomes Métastase tumorale Adénocarcinome Tumeurs de l'oesophage Carcinome épidermoïde Tumeurs du côlon Carcinome épidermoïde de l'oesophage

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France
Bedenne Laurent
Bedenne Laurent
Sncf Mobilites, Paris, France
Aparicio Thomas
Aparicio Thomas
Hôpital Avicenne, Bobigny, France

Industries

Voir plus
Ipsen
4 collaboration(s)
Dernière en 2021
Servier
2 collaboration(s)
Dernière en 2021
Sanofi
1 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
629P First results of the french prospective cohort of colorectal cancers with microsatellite instability (COLOMIN2)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Néofirinox: Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer
Essai Clinique (Unicancer)   30 août 2023
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   12 juin 2023
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.
European journal of cancer (Oxford, England : 1990)   24 mars 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
1296MO PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study.
2022 ASCO Annual Meeting I   02 juin 2022
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus: Phase I-II on Radiochemotherapy Combined With Panitumumab in the Treatment of Localised Epidermoid Carcinoma of the Anus
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   23 mars 2022